Healthineers sharpens ultrasound focus. Siemens Healthineers stock sits 17.22 percent below its high

Published on 10/21/2026 at 09:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

General ultrasound sales ended October 12, 2026. Siemens Healthineers stock costs EUR 41.14 on October 21, 2026, 0.72 percent below its EUR 41.44 Xetra close.

Portfolio shift and reporting dates

On October 12, 2026, Siemens Healthineers ended sales of four general-imaging ultrasound systems.
Third-quarter revenue reached EUR 5.764 billion in fiscal 2026.
Siemens Healthineers stock trades at EUR 41.14 at 9:06 a.m. CEST at Lang & Schwarz on October 21, 2026, 0.72 percent below the Xetra close of October 20, 2026.
Siemens Healthineers is scheduled to report fourth-quarter and full-year results on November 5, 2026.

Fotorealistischer Klinikraum mit neutralem MRT-Scanner und Patientenliege — Siemens Healthineers DE000SHL1006 zeigt fotorealistischen Radiologieraum mit neutraler MRT-Röhre und Patientenliege in Klinik, Illustration mit AI erstellt.

Siemens Healthineers (ISIN DE000SHL1006) was trading at EUR 41.14 at Lang & Schwarz on October 21, 2026 at 9:06 a.m. CEST, down 0.72 percent versus the Xetra close of October 20, 2026 at EUR 41.44. On October 12, 2026, the company sharpened its ultrasound strategy toward procedural imaging and image-guided therapy, as Siemens Healthineers reported.

Ultrasound shifts toward procedures

The company said general-imaging ultrasound sales ended on October 12, 2026, covering the Acuson Sequoia, Redwood, Juniper and Maple systems. Its continuing portfolio includes procedural systems, software and catheters for electrophysiologists and interventional cardiologists, according to Siemens Healthineers.

Third-quarter figures set the test

For the third quarter of fiscal 2026, revenue was EUR 5.764 billion and net income was EUR 669.0 million, while diluted earnings per share reached EUR 0.60, according to the Yahoo Finance transcript dated July 31, 2026. Management lowered fiscal 2026 revenue-growth guidance to 3.5 percent to 4.0 percent and raised adjusted earnings-per-share guidance to EUR 2.35 to EUR 2.45 after tariff refunds.

Three dated company signals

On July 31, 2026, Siemens Healthineers reported a third-quarter equipment book-to-bill ratio of 1.27 in the earnings call. On October 12, 2026, the company reported that 50,000 shares had been repurchased between October 5 and October 11, according to Deutsche Boerse. The ultrasound strategy followed on the same date, making portfolio focus the latest of these three dated signals.

When are the next dates?

Siemens Healthineers is scheduled to publish fourth-quarter and full-year results on November 5, 2026, followed by a US roadshow on November 6, 2026, according to the company's investor-relations calendar.

What does the valuation show?

Siemens Healthineers had a market capitalization of EUR 46.4 billion as of October 20, 2026. Its Xetra quote had a 52-week range of EUR 32.81 to EUR 49.71, putting the Lang & Schwarz price 17.22 percent below the high. For investors, the upcoming report must show whether stronger procedural businesses can offset continued pressure in Diagnostics.

Stock trades below yearly high

At Lang & Schwarz, Siemens Healthineers was trading at EUR 41.14 on October 21, 2026 at 9:06 a.m. CEST, down 0.72 percent versus the Xetra close of October 20, 2026 at EUR 41.44. The further course of trading is shown by the continuously updated real-time quote of Siemens Healthineers stock.